Twist Stock Buy Hold or Sell Recommendation


USD 28.41  0.09  0.32%   

Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Twist Bioscience Corp is 'Cautious Hold'. Macroaxis provides Twist Bioscience buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TWST positions. The advice algorithm takes into account all of Twist Bioscience's available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from Twist Bioscience's buy-and-hold perspective. Additionally, take a look at Twist Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Twist and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Twist Bioscience Corp.

Execute Twist Bioscience Buy or Sell Advice

The Twist recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Twist Bioscience Corp. Macroaxis does not own or have any residual interests in Twist Bioscience Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Twist Bioscience's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Twist BioscienceBuy Twist Bioscience
Cautious Hold



Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

For the selected time horizon Twist Bioscience Corp has a Mean Deviation of 4.37, Standard Deviation of 6.36 and Variance of 40.5
Our trade recommendation module complements current analysts and expert consensus on Twist Bioscience Corp. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time. To make sure Twist Bioscience Corp is not overpriced, please validate all Twist Bioscience fundamentals, including its total debt, and the relationship between the revenue and earnings per share . Given that Twist Bioscience Corp has a number of shares shorted of 6.08 M, we advise you to double-check Twist Bioscience Corp market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Twist Bioscience Trading Alerts and Improvement Suggestions

Twist Bioscience generated a negative expected return over the last 90 days
Twist Bioscience has high historical volatility and very poor performance
The company reported the previous year's revenue of 203.56 M. Net Loss for the year was (217.86 M) with profit before overhead, payroll, taxes, and interest of 84.23 M.
Twist Bioscience Corp currently holds about 504.97 M in cash with (124.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.93.
Twist Bioscience has a frail financial position based on the latest SEC disclosures
Over 99.0% of the company shares are owned by institutional investors

Twist Bioscience Returns Distribution Density

The distribution of Twist Bioscience's historical returns is an attempt to chart the uncertainty of Twist Bioscience's future price movements. The chart of the probability distribution of Twist Bioscience stock daily returns describes the distribution of returns around its average expected value. We use Twist Bioscience Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Twist Bioscience returns is essential to provide solid investment advice for Twist Bioscience.
Mean Return-0.32Value At Risk-10.22
Potential Upside9.60Standard Deviation6.36
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Twist Bioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Twist Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Twist Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Twist Bioscience Corp backward and forwards among themselves. Twist Bioscience's institutional investor refers to the entity that pools money to purchase Twist Bioscience's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zweigdimenna Associates LlcCommon Shares7.5 K805 K
Zweigdimenna Associates LlcCommon Shares7.5 KM
Zurcher Kantonalbank Zurich CantonalbankCommon Shares8.4 K297 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares8.6 K299 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares8.6 K427 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares8.5 K654 K
Zurcher Kantonalbank Zurich CantonalbankCommon SharesK753 K
Note, although Twist Bioscience's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Twist Bioscience Cash Flow Accounts

201720182019202020212022 (projected)
Net Cash Flow from Financing88.82 M158.58 M303.73 M329.18 M296.26 M319.65 M
Net Cash Flow from Investing26.87 M(104.81 M)(114.65 M)156.16 M140.54 M151.63 M
Net Cash Flow from Operations(66.16 M)(87.94 M)(142.25 M)(112.24 M)(129.08 M)(139.27 M)

Twist Bioscience Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Twist Bioscience or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Twist Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Twist stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over NYSE Composite
Beta against NYSE Composite2.70
Overall volatility
Information ratio -0.07

Twist Bioscience Volatility Alert

Twist Bioscience Corp is displaying above-average volatility over the selected time horizon. Investors should scrutinize Twist Bioscience Corp independently to ensure intended market timing strategies are aligned with expectations about Twist Bioscience volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Twist Bioscience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Twist Bioscience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Twist Bioscience Fundamentals Vs Peers

Comparing Twist Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Twist Bioscience's direct or indirect competition across all of the common fundamentals between Twist Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Twist Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Twist Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Twist Bioscience by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Twist Bioscience to competition
FundamentalsTwist BiosciencePeer Average
Return On Equity(0.32) %(0.31) %
Return On Asset(0.19) %(0.14) %
Profit Margin(1.07) %(1.27) %
Operating Margin(1.22) %(5.51) %
Current Valuation1.2 B16.62 B
Shares Outstanding56.57 M571.82 M
Shares Owned by Insiders1.00 %10.09 %
Shares Owned by Institutions99.00 %39.21 %
Number of Shares Shorted6.08 M4.71 M
Price to Book1.76 X9.51 X
Price to Sales7.92 X11.42 X
Revenue203.56 M9.43 B
Gross Profit84.23 M27.38 B
EBITDA(190.86 M)3.9 B
Net Income(217.86 M)570.98 M
Cash and Equivalents504.97 M2.7 B
Cash per Share8.93 X5.01 X
Total Debt94.91 M5.32 B
Debt to Equity0.12 %48.70 %
Current Ratio6.58 X2.16 X
Book Value Per Share13.97 X1.93 K
Cash Flow from Operations(124.39 M)971.22 M
Short Ratio4.74 X4.00 X
Earnings Per Share(3.72) X3.12 X
Price to Earnings To Growth(0.04) X4.89 X
Target Price37.57
Number of Employees98918.84 K
Market Capitalization1.61 B19.03 B
Total Asset961.38 M29.47 B
Z Score9.68.72
Net Asset961.38 M
   Payment of tradable shares by Kevin Yankton of Twist Bioscience subject to Rule 16b-3 [view details]

Twist Bioscience Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Twist . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Twist Bioscience Buy or Sell Advice

When is the right time to buy or sell Twist Bioscience Corp? Buying financial instruments such as Twist Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Receivables26.38 M28.55 M25.69 M27.72 M
Inventories12.29 M31.8 M28.62 M30.88 M

Use Investing Ideas to Build Portfolios

In addition to having Twist Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Baby Boomer Prospects Thematic Idea Now

Baby Boomer Prospects
Baby Boomer Prospects Theme
Equities with large market capitalization that account for significant contribution to overall economic growth especially within dividend-paying instruments and stocks from healthcare and financial sectors. The Baby Boomer Prospects theme has 87 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Baby Boomer Prospects Theme or any other thematic opportunities.
View All  Next Launch
Additionally, take a look at Twist Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for analysis

When running Twist Bioscience Corp price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEO Directory
Screen CEOs from public companies around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.6 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine Twist Bioscience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.